MoneyWorks4Me

Ambalal Sarabhai Enterprises informs about press release

18 Aug 2022 Evaluate
Ambalal Sarabhai Enterprises has informed that it enclosing the copies of Newspaper Clippings of the publication of the Extract of the Un-audited Financial Results (Standalone and Consolidated) for the Quarter and ended on June 30, 2022 published in 'Business Standard' (English) & Jansatta - Loksatta (Gujarati) - Ahmedabad on August 11, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..